/Nelson Cabatuan/ - 14 Mar 2024 Form 3 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Nelson Cabatuan/
Issuer symbol
LEXX
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
3
Filing time
15 Mar 2024, 16:22:43 UTC
Previous filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 14 Mar 2024 Common Shares 200,000 $2.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 options are exercisable on March 15, 2024, an additional 50,000 options are exercisable on March 15, 2025, thereafter an additional 4,166 options are exercisable monthly until Feb. 15, 2027 with the balance of 4,182 options being exercisable on March 15, 2027